Medical Weight Loss Pill. No Needles

Oral semaglutide is a once-daily tablet containing semaglutide, a GLP-1 receptor agonist clinically proven to suppress appetite and support sustained weight loss. It delivers the same active ingredient as the Wegovy injection but in tablet form. It is the first oral GLP-1 treatment to receive approval specifically for weight management in the US.

Both treatments use semaglutide as the active ingredient, but the pill is swallowed once daily while the injection is administered once weekly. For men who want to avoid needles entirely, the pill offers the same proven mechanism in a simpler daily format. For best absorption, the tablet should be taken on an empty stomach with a small amount of water, waiting 30 minutes before eating, drinking, or taking other oral medications.

The Wegovy pill targets GLP-1 receptors only, while Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist that works across two hormonal pathways simultaneously. Mounjaro is currently available in injectable form only, making the Wegovy pill the only needle-free option currently available at HeMed. Your HeMed clinician will recommend the most appropriate treatment based on your health profile and weight loss goals.

Nausea, vomiting, and digestive discomfort are the most commonly reported side effects, consistent with other GLP-1 medications, and typically ease within the first few weeks of treatment. To minimise these, the tablet should be taken on an empty stomach with a small amount of water: wait 30 minutes before eating, drinking, or taking other oral medications. HeMed’s clinical team will monitor your health and support you throughout your treatment.

The Wegovy pill is available in four doses: 1.5mg, 4mg, 9mg, and 25mg. Most men begin on the 1.5mg starting dose and increase gradually under clinical guidance based on their response and tolerance. Your HeMed clinician will determine the right titration schedule for you. Each dose is priced individually, so your monthly price follows your prescribed dose, and plan discounts apply at every dose. The full breakdown is in the pricing table above.

The Wegovy pill is designed for adults with a BMI of 30 or above, or 27+ alongside a weight-related condition such as high blood pressure or type 2 diabetes. It is a strong option for men who want clinically proven weight loss results without weekly injections. A full clinical review is required before prescribing to confirm suitability.

Oral semaglutide has been assessed across large-scale clinical trials and carries a well-established safety profile consistent with injectable semaglutide. Like all prescription weight loss treatments, it requires a full clinical assessment before it can be prescribed. HeMed’s clinicians review your complete health history to ensure the treatment is appropriate for you before you begin.

The Wegovy pill starts from £69 for your first month on a 12-month plan, £79 on a 6-month plan, or £89 on a 3-month plan, with blood tests and clinical support included. After your first month, pricing depends on your dose, starting at £154 a month on a rolling basis, and commitment plans take £10 to £25 off every month. The full dose-by-dose breakdown is shown above, and plan terms, including cancellation, are confirmed at sign-up.

Click Get Started and complete a short eligibility questionnaire. It takes around two minutes. Once confirmed as eligible, you’ll complete an at-home blood test and clinical review before your medication is prescribed and dispatched to your door. No payment or commitment is required until eligibility is confirmed.

Yes. Whether you’re an existing HeMed member or currently with another provider, switching to the Wegovy pill can be discussed with your HeMed clinician. Any switch is assessed on the basis of your current progress, health history, and clinical suitability. Contact your HeMed clinician or our support team to explore your options.